Year |
Citation |
Score |
2023 |
Jacobsen E, Logallo N, Kvistad CE, Thomassen L, Idicula T. Characteristics and predictors of stroke mimics in young patients in the norwegian tenecteplase stroke trial (NOR-TEST). Bmc Neurology. 23: 406. PMID 37968581 DOI: 10.1186/s12883-023-03425-x |
0.8 |
|
2022 |
Kvistad CE, Næss H, Helleberg BH, Idicula T, Hagberg G, Nordby LM, Jenssen KN, Tobro H, Rörholt DM, Kaur K, Eltoft A, Evensen K, Haasz J, Singaravel G, Fromm A, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. The Lancet. Neurology. 21: 511-519. PMID 35525250 DOI: 10.1016/S1474-4422(22)00124-7 |
0.781 |
|
2019 |
Ratajczak-Tretel B, Lambert AT, Johansen H, Halvorsen B, Bjerkeli V, Russell D, Sandset EC, Ihle-Hansen H, Eriksen E, Næss H, Novotny V, Khanevski AN, Truelsen TC, Idicula T, Ægidius KL, et al. Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design. European Stroke Journal. 4: 172-180. PMID 31259265 DOI: 10.1177/2396987319837089 |
0.595 |
|
2017 |
Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, Rønning OM, Thommessen B, Amthor KF, Ihle-Hansen H, Kurz M, Tobro H, Kaur K, Stankiewicz M, Carlsson M, Morsund Å, ... Idicula T, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. The Lancet. Neurology. 16: 781-788. PMID 28780236 DOI: 10.1016/S1474-4422(17)30253-3 |
0.79 |
|
2017 |
Myren-Svelstad S, Hammer TA, Idicula TT. Early Thrombectomy of a Proximal Middle Cerebral Artery Occlusion Leading to Complete Recovery with No Infarct. Case Reports in Neurology. 9: 76-80. PMID 28559829 DOI: 10.1159/000468922 |
0.38 |
|
2015 |
Nacu A, Kvistad CE, Logallo N, Naess H, Waje-Andreassen U, Aamodt AH, Solhoff R, Lund C, Tobro H, Rønning OM, Salvesen R, Idicula TT, Thomassen L. A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS). Bmc Neurology. 15: 110. PMID 26162826 DOI: 10.1186/S12883-015-0359-4 |
0.789 |
|
2014 |
Logallo N, Kvistad CE, Nacu A, Naess H, Waje-Andreassen U, Asmuss J, Aamodt AH, Lund C, Kurz MW, Rønning OM, Salvesen R, Idicula TT, Thomassen L. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. Bmc Neurology. 14: 106. PMID 24886064 DOI: 10.1186/1471-2377-14-106 |
0.786 |
|
2013 |
Naess H, Nyland H, Idicula T, Waje-Andreassen U. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 22: e435-40. PMID 23735372 DOI: 10.1016/J.Jstrokecerebrovasdis.2013.04.031 |
0.74 |
|
2012 |
Logallo N, Lind J, Naess H, Idicula T, Brogger J, Waje-Andreassen U, Thomassen L. Middle cerebral artery stenosis: transcranial color-coded sonography based on continuity equation versus CT-angiography. Ultraschall in Der Medizin (Stuttgart, Germany : 1980). 33: E326-32. PMID 22872381 DOI: 10.1055/S-0032-1313076 |
0.662 |
|
2011 |
Logallo N, Naess H, Idicula TT, Brogger J, Waje-Andreassen U, Thomassen L. Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. Bmc Neurology. 11: 114. PMID 21943291 DOI: 10.1186/1471-2377-11-114 |
0.688 |
|
2011 |
Naess H, Idicula T, Brogger J, Waje-Andreassen U, Thomassen L. High proportion of lacunar strokes at night: the Bergen stroke study. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 20: 424-8. PMID 20692855 DOI: 10.1016/J.Jstrokecerebrovasdis.2010.02.014 |
0.801 |
|
2010 |
Idicula TT, Naess H, Thomassen L. Microemboli-monitoring during the acute phase of ischemic stroke: is it worth the time? Bmc Neurology. 10: 79. PMID 20831778 DOI: 10.1186/1471-2377-10-79 |
0.709 |
|
2010 |
Naess H, Idicula T, Lagallo N, Brogger J, Waje-Andreassen U, Thomassen L. Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: the Bergen stroke study. Acta Neurologica Scandinavica. 122: 414-7. PMID 20199522 DOI: 10.1111/J.1600-0404.2010.01331.X |
0.683 |
|
2009 |
Naess H, Brogger JC, Idicula T, Waje-Andreassen U, Moen G, Thomassen L. Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke Study. Bmc Neurology. 9: 44. PMID 19689814 DOI: 10.1186/1471-2377-9-44 |
0.757 |
|
2009 |
Idicula TT, Thomassen L. Case report of a patient who underwent thrombolysis of a "silent" thrombus in the middle cerebral artery. The Neurologist. 15: 142-3. PMID 19430268 DOI: 10.1097/Nrl.0B013E3181824741 |
0.494 |
|
2009 |
Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Thomassen L. Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study. Cerebrovascular Diseases (Basel, Switzerland). 28: 13-7. PMID 19420917 DOI: 10.1159/000215938 |
0.793 |
|
2009 |
Naess H, Brogger J, Waje-Andreassen U, Idicula TT, Thomassen L. Preadmission use of warfarin improves short-term outcome in patients with acute cerebral infarction. The Bergen Stroke Study. Cerebrovascular Diseases (Basel, Switzerland). 28: 8-12. PMID 19420916 DOI: 10.1159/000215937 |
0.707 |
|
2009 |
Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. Bmc Neurology. 9: 18. PMID 19400931 DOI: 10.1186/1471-2377-9-18 |
0.77 |
|
2008 |
Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Lundstadsveen MT, Thomassen L. The effect of physiologic derangement in patients with stroke treated with thrombolysis. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 17: 141-6. PMID 18436155 DOI: 10.1016/J.Jstrokecerebrovasdis.2008.01.010 |
0.755 |
|
Show low-probability matches. |